Stock listing
NASDAQ:ZJYL Jin Medical International Ltd. Stock
Home listing (NASDAQ) of Jin Medical International Ltd.
Follow Jin Medical International Ltd. into a list and get an email when it puts out news.
Share price · NASDAQ:ZJYL
$3.38 USD +0.02 (+0.6%)
Close on Nov 20, 2026
- Day range
- $3.30 – $3.43 USDNov 20, 2026
- Volume
- 32,431 sharesNov 20, 2026
- Market cap
- $518.6M USDAt the close on Nov 20, 2026 · price × 153.4M shares outstanding
- 52-week range
- $1.53 – $5.60 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $310,167 USDMedian day 20,900 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ZJYL · Home | $3.38 USD | +0.02 (+0.6%) | 32,431 | $3.35 | $3.429 | $3.30 | $3.36 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ZJYL · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.38 | +0.02 | +0.6% | $3.35 | $3.429 | $3.30 | 32,431 | |
| $3.36 | -0.015 | -0.4% | $3.293 | $3.44 | $3.293 | 3,926 | |
| $3.375 | -0.255 | -7.0% | $3.616 | $3.62 | $3.214 | 24,797 | |
| $3.63 | +0.13 | +3.7% | $3.50 | $3.77 | $3.43 | 34,249 | |
| $3.50 | -0.37 | -9.6% | $3.601 | $3.601 | $3.415 | 18,789 | |
| $3.87 | -1.04 | -21.2% | $4.68 | $4.68 | $3.01 | 153,588 | |
| $4.91 | +0.70 | +16.6% | $4.27 | $4.95 | $4.215 | 228,826 | |
| $4.21 | +0.26 | +6.6% | $3.84 | $4.26 | $3.78 | 131,128 | |
| $3.95 | +0.59 | +17.6% | $3.36 | $3.95 | $3.36 | 98,848 | |
| $3.36 | +0.14 | +4.3% | $3.08 | $3.36 | $2.93 | 65,600 | |
| $3.22 | +0.13 | +4.2% | $2.99 | $3.22 | $2.98 | 47,200 | |
| $3.09 | +0.37 | +13.6% | $2.80 | $3.09 | $2.502 | 83,500 | |
| $2.72 | +0.52 | +23.6% | $2.33 | $2.72 | $2.25 | 126,700 | |
| $2.20 | -0.15 | -6.4% | $2.33 | $2.42 | $2.074 | 89,300 | |
| $2.35 | +0.49 | +26.3% | $1.90 | $2.83 | $1.83 | 3,686,400 | |
| $1.86 | -0.04 | -2.1% | $1.91 | $1.91 | $1.86 | 1,600 | |
| $1.90 | -0.093 | -4.7% | $1.97 | $2.094 | $1.86 | 22,200 | |
| $1.993 | +0.053 | +2.7% | $1.954 | $2.055 | $1.90 | 31,500 | |
| $1.94 | -0.11 | -5.4% | $1.931 | $2.038 | $1.931 | 2,400 | |
| $2.05 | +0.03 | +1.5% | $1.92 | $2.05 | $1.92 | 4,200 | |
| $2.02 | -0.071 | -3.4% | $1.947 | $2.09 | $1.92 | 3,400 | |
| $2.091 | +0.061 | +3.0% | $1.935 | $2.15 | $1.85 | 71,700 | |
| $2.03 | -0.08 | -3.8% | $2.07 | $2.16 | $2.00 | 3,700 | |
| $2.11 | +0.03 | +1.4% | $2.111 | $2.14 | $2.017 | 9,900 | |
| $2.08 | -0.075 | -3.5% | $2.18 | $2.24 | $2.08 | 17,300 | |
| $2.155 | +0.135 | +6.7% | $2.04 | $2.155 | $1.992 | 4,000 | |
| $2.02 | -0.04 | -1.9% | $2.00 | $2.10 | $1.99 | 15,600 | |
| $2.06 | -0.14 | -6.4% | $2.10 | $2.15 | $2.025 | 8,100 | |
| $2.20 | +0.14 | +6.8% | $2.06 | $2.22 | $2.00 | 25,100 | |
| $2.06 | -0.06 | -2.8% | $2.05 | $2.112 | $1.97 | 12,100 | |
| $2.12 | 0.00 | 0.0% | $2.085 | $2.234 | $2.005 | 13,200 | |
| $2.12 | +0.13 | +6.5% | $1.922 | $2.12 | $1.922 | 22,200 | |
| $1.99 | +0.01 | +0.5% | $1.96 | $1.99 | $1.911 | 5,000 | |
| $1.98 | +0.04 | +2.1% | $1.894 | $2.025 | $1.894 | 6,000 | |
| $1.94 | -0.06 | -3.0% | $1.97 | $1.99 | $1.94 | 3,700 | |
| $2.00 | +0.09 | +4.7% | $1.98 | $2.00 | $1.92 | 10,100 | |
| $1.91 | +0.03 | +1.6% | $1.955 | $2.05 | $1.91 | 12,200 | |
| $1.88 | -0.07 | -3.6% | $1.86 | $1.93 | $1.86 | 7,400 | |
| $1.95 | +0.04 | +2.1% | $2.00 | $2.00 | $1.85 | 14,000 | |
| $1.91 | -0.09 | -4.5% | $1.94 | $2.01 | $1.90 | 33,100 | |
| $2.00 | -0.05 | -2.4% | $1.99 | $2.079 | $1.91 | 367,500 | |
| $2.05 | -0.03 | -1.4% | $2.07 | $2.18 | $2.02 | 19,100 | |
| $2.08 | +0.01 | +0.5% | $2.05 | $2.11 | $1.925 | 12,900 | |
| $2.07 | +0.08 | +4.0% | $2.02 | $2.07 | $1.94 | 9,200 | |
| $1.99 | +0.01 | +0.5% | $2.06 | $2.06 | $1.893 | 8,000 | |
| $1.98 | +0.01 | +0.5% | $2.06 | $2.08 | $1.883 | 9,300 | |
| $1.97 | -0.02 | -1.0% | $1.985 | $2.013 | $1.87 | 13,800 | |
| $1.99 | +0.02 | +1.0% | $1.97 | $1.99 | $1.92 | 11,700 | |
| $1.97 | -0.10 | -4.8% | $2.09 | $2.09 | $1.85 | 16,400 | |
| $2.07 | +0.01 | +0.5% | $2.05 | $2.13 | $2.01 | 18,700 | |
| $2.06 | -0.19 | -8.4% | $2.20 | $2.229 | $2.023 | 50,500 | |
| $2.25 | +0.23 | +11.4% | $1.97 | $2.31 | $1.84 | 837,700 | |
| $2.02 | -0.06 | -2.9% | $2.07 | $2.09 | $2.00 | 1,176,600 | |
| $2.08 | -0.07 | -3.3% | $2.14 | $2.276 | $2.07 | 27,800 | |
| $2.15 | +0.05 | +2.4% | $2.15 | $2.27 | $2.15 | 22,800 | |
| $2.10 | -0.10 | -4.5% | $2.19 | $2.20 | $2.10 | 27,500 | |
| $2.20 | -0.12 | -5.2% | $2.32 | $2.553 | $2.20 | 13,400 | |
| $2.32 | -0.02 | -0.9% | $2.34 | $2.415 | $2.32 | 20,900 | |
| $2.34 | -0.01 | -0.4% | $2.36 | $2.52 | $2.34 | 17,400 | |
| $2.35 | -0.44 | -15.8% | $2.78 | $2.80 | $2.35 | 57,800 | |
| $2.79 | +0.02 | +0.7% | $2.81 | $2.975 | $2.71 | 31,600 | |
| $2.77 | -0.27 | -8.9% | $3.02 | $3.28 | $2.70 | 87,900 | |
| $3.04 | 0.00 | 0.0% | $3.09 | $3.28 | $3.02 | 55,700 | |
| $3.04 | +0.01 | +0.3% | $3.10 | $3.183 | $3.04 | 40,000 | |
| $3.03 | -0.05 | -1.6% | $3.08 | $3.15 | $2.97 | 51,100 |
Splits
2 splits since 2024 · NASDAQ:ZJYL · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-20 | Consolidation | |
| 20-for-1 | Split |
- Ticker
- NASDAQ:ZJYL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news
Jin Medical Supports the 12th Jiangsu Provincial Games for Persons with Disabilities with Professional Wheelchairs and Accessibility Services
Nov 3, 2026
Closed $2.72 (+23.6%) on Nov 3, 2026
Jin Medical Showcases Innovation Across Four Global Industry Expos: Lightweight Rehabilitation Assistive Line Draws Broad Market Attention
Nov 2, 2026
Closed $2.20 (-6.4%) on Nov 2, 2026
JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results
Aug 4, 2026
Closed $2.21 (+13.9%) on Aug 5, 2026
Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement
Apr 7, 2026
Closed $2.01 (+1.5%) on Apr 7, 2026
Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative
Mar 11, 2026
Closed $2.84 (0.0%) on Mar 11, 2026
Annual Report for Fiscal Year Ending September 30, 2025 (Form 20-F)
Feb 10, 2026
Closed $2.80 (0.0%) on Feb 10, 2026
Jin Medical CEO Fireside Chat
Feb 5, 2026
Closed $2.84 (+1.4%) on Feb 5, 2026
Jin Medical International Ltd. To Host Management Fireside Chat
Jan 26, 2026
Closed $2.82 (+5.2%) on Jan 26, 2026
Jin Medical Announces the Official Commencement Date of Chuzhou Facility
Jan 22, 2026
Closed $2.62 (+3.1%) on Jan 22, 2026
Jin Medical International Ltd. Management Plans For Fireside Chat
Jan 21, 2026
Closed $2.54 (-3.8%) on Jan 21, 2026
Jin Medical International Ltd. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 10 in the last 12 months · 31 in all · newest Nov 3, 2026 · oldest 2023
Where Jin Medical International Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ZJYL · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ZJYL | BOATS | United States | USD |
Valuation
P/E 435× against a median of 25.9×: the highest of 7 Medical devices & supplies companies shown. Statements: Year to Sep 30, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $509.1M USD
- P/E
- 435×
- EV/sales
- 24.6×
- EV/EBITDA
- 598×
- Price/book
- 17.1×
- Gross margin
- 29.2%
- Operating margin
- 2.9%
- Net margin
- 5.8%
- Debt to equity
- 0.7×
- Beta vs S&P 500
- 0.92
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Jin Medical International Ltd. · NASDAQ:ZJYL | US$518.6M | US$509.1M | 435× | 24.6× | 598× | 17.1× | 5.8% | 0.7× | 0.92 |
| Visco Vision Inc. · TWSE:6782 | US$541.8M | US$572.3M | 15.1× | 3.8× | 9.3× | 3.7× | 23.5% | 0.4× | n/a |
| Ningbo David Medical Device Co., Ltd. Class A · SZSE:300314 | US$529.5M | US$435.6M | 38.3× | 4.7× | n/a | 2.7× | 15.0% | 0.0× | n/a |
| LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H · HKEX:2291 | US$525.3M | US$332.3M | 14.6× | 4.2× | 7.2× | 1.8× | 45.4% | 0.0× | n/a |
| Zhejiang Gongdong Medical Technology Co. Ltd. Class A · SSE:605369 | US$512.0M | US$407.8M | 47.7× | 2.3× | n/a | 2.0× | 6.0% | 0.0× | n/a |
| Ion Beam Applications SA · EURONEXT:IBAB | US$511.8M | US$593.9M | 36.6× | 0.9× | 12.9× | 3.9× | 2.1% | 1.0× | n/a |
| Contec Medical Systems Co. Ltd. Class A · SZSE:300869 | US$506.6M | US$348.7M | n/a | 4.9× | n/a | 2.0× | −19.1% | 0.5× | n/a |
| Beijing Chunlizhengda Medical Instruments Co., Ltd. Class A · SSE:688236 | US$494.6M | US$175.5M | 12.1× | 1.1× | 3.5× | 1.1× | 26.1% | 0.0× | n/a |
| Avita Medical, Inc. · NASDAQ:RCEL | US$490.8M | US$525.8M | n/a | 6.2× | n/a | n/a | −42.6% | n/a | 1.37 |
| Chimin Health Management Co., Ltd. Class A · SSE:603222 | US$487.9M | US$484.6M | n/a | 5.0× | n/a | 3.1× | −39.2% | 0.2× | n/a |
| Anteris Technologies Global Corp. · NASDAQ:AVR | US$486.5M | US$269.6M | n/a | 116× | n/a | 2.1× | n/a | 0.0× | 1.43 |
| Median of the others | US$509.2M | US$421.7M | 25.9× | 4.5× | 8.3× | 2.1× | 6.0% | 0.0× | 1.40 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2026 | Jan 23, 2026 · After close | +5.2% |
| Q3 2025 | Aug 20, 2025 | −5.5% |
| Q1 2025 | Jan 24, 2025 | −10.1% |
| Q1 2023 | Mar 21, 2023 | |
| Q4 2022 | Dec 20, 2022 | |
| Q4 2021 | Dec 10, 2021 | |
| Quarter to Jun 30, 2021 | Sep 24, 2021 |
IPO
Priced at US$8.00 a share on Mar 27, 2023.
- Price
- US$8.00 a share
- Shares offered
- 1,000,000 ordinary shares
- Offering size
- US$8 million
- Listing
- ZJYL on the Nasdaq Capital Market
- Shares delivered
- On or about Mar 30, 2023
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Dec 28, 2020 |
| Filed publicly | Sep 24, 2021 |
| Amended 13 times | Newest Mar 21, 2023 |
| Shares registered with an exchange | Mar 23, 2023 |
| Declared effective by the SEC | Mar 27, 2023 |
| Final prospectus, with the price | Mar 29, 2023 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Mar 29, 2023 |
| CERT · Exchange's certificate of listing | Mar 28, 2023 |
| EFFECT · Notice that a registration is effective | Mar 27, 2023 |
| 8-A12B · Registration of shares for listing on an exchange | Mar 23, 2023 |
| CORRESP · Letter to the SEC | Mar 23, 2023 |
| CORRESP · Letter to the SEC | Mar 23, 2023 |
| F-1/A · Registration statement, amended | Mar 21, 2023 |
| CORRESP · Letter to the SEC | Mar 7, 2023 |
| F-1/A · Registration statement, amended | Mar 7, 2023 |
| UPLOAD · Letter from the SEC | Mar 2, 2023 |
All 44 filings
Open IPO · From the cover of the final prospectus (424B4) filed Mar 29, 2023
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 20.7M | 23.5M | 19.8M | 19.2M | 20.8M | 16.2M | 20.4M | 20.9M |
| Cost of revenue | 14.6M | 14.0M | 13.0M | 13.0M | 14.4M | 10.7M | 12.9M | 13.3M |
| Gross profit | 6.04M | 9.50M | 6.78M | 6.20M | 6.36M | 5.50M | 7.51M | 7.66M |
| Research and development | 1.56M | 1.50M | 1.54M | 1.89M | 1.57M | 1.26M | 1.13M | 1.20M |
| Selling, general and administrative | 2.53M | 3.26M | 2.37M | 1.77M | 1.67M | 1.50M | 1.60M | 1.72M |
| Operating income | 608.2K | 3.64M | 2.87M | 2.13M | 2.63M | 2.35M | 4.40M | 4.23M |
| Depreciation and amortization | 243.4K | 237.8K | 225.9K | 362.6K | 346.6K | 324.9K | 344.0K | 368.3K |
| EBITDA | 851.6K | 3.88M | 3.09M | 2.49M | 2.98M | 2.68M | 4.75M | 4.60M |
| Interest expense | 9.49K | 112.4K | 22.8K | |||||
| Income before tax | 1.60M | 4.18M | 3.22M | 2.74M | 2.88M | 2.35M | 4.13M | 4.30M |
| Income tax | 214.6K | 763.9K | 343.7K | 36.1K | 248.6K | 147.2K | 479.6K | 616.9K |
| Net income | 1.19M | 3.68M | 2.88M | 2.71M | 2.63M | 2.21M | 3.65M | 3.68M |
| Earnings per share, basic | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.11 | 0.18 | 0.18 |
| Earnings per share, diluted | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 7.46M | 8.14M | 6.93M | 4.79M | 3.67M | 1.66M | 1.94M | 853.3K |
| Short-term investments | 22.2M | 18.6M | 9.77M | 2.28M | 2.05M | 1.18M | 1.40M | 1.60M |
| Receivables | 5.81M | 5.91M | 3.28M | 3.83M | 5.98M | 7.86M | 8.63M | 6.34M |
| Inventory | 4.92M | 5.17M | 5.05M | 6.72M | 7.04M | 7.25M | 5.74M | 6.06M |
| Current assets | 44.1M | 42.8M | 31.1M | 18.9M | 19.4M | 18.2M | 17.7M | 15.6M |
| Property, plant and equipment | 7.90M | 1.46M | 1.48M | 1.63M | 2.11M | 2.31M | 2.38M | |
| Total assets | 53.4M | 45.8M | 32.9M | 20.9M | 21.9M | 20.8M | 20.4M | 18.7M |
| Accounts payable | 3.26M | 3.01M | 3.39M | 4.11M | 5.35M | 5.43M | 4.76M | 7.75M |
| Current liabilities | 23.8M | 17.2M | 8.92M | 5.70M | 7.87M | 10.0M | 9.66M | 9.68M |
| Total debt | 18.9M | 11.6M | 2.65M | 2.87M | 712.5K | |||
| Total liabilities | 23.8M | 17.2M | 8.92M | 5.70M | 7.87M | 10.0M | 9.66M | 9.68M |
| Shareholders' equity | 29.6M | 28.8M | 24.0M | 15.2M | 14.0M | 10.8M | 10.7M | 9.00M |
| Shares outstanding | 156.5M | 155.9M | 155.9M | 135.0M | 156.5M | 20.0M | 20.0M | 20.0M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 2.90M | -1.21M | 3.11M | 1.58M | 5.84M | 2.50M | -1.33M | -2.39M |
| Capital spending | -6.63M | -144.9K | -113.9K | -40.2K | -42.9K | -142.3K | -73.3K | -187.7K |
| Free cash flow | -3.73M | -1.35M | 2.99M | 1.54M | 5.80M | 2.36M | -1.40M | -2.58M |
| Cash from investing | -10.8M | -9.51M | -7.73M | -120.9K | -1.07M | -1.96M | 126.9K | 1.96M |
| Cash from financing | 7.35M | 11.7M | 6.91M | 121.9K | -2.87M | -343.9K | 2.36M | -3.19M |
| Change in cash | -674.5K | 1.21M | 2.14M | 1.12M | 2.01M | -278.4K | 1.09M | -3.59M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| F-3ASR | Nov 20, 2026 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Oct 30, 2026 | Current report | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Sep 25, 2026 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Sep 24, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Sep 8, 2026 | Current report | SEC |
| SCHEDULE 13D · Big-stake notice | Aug 21, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 18, 2026 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Aug 4, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Jul 20, 2026 | Current report | SEC |
| 3 · Initial statement of ownership | Jul 16, 2026 | Insider trade | SEC |
All 116 filings
Cap table
Built by 6ix from Jin Medical International Ltd.’s releases
- Common shares
- 153,425,476
- Fully diluted
- 153,425,476
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 153,425,476 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 153,425,476 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Jiayuan Tong Other companies: Horizon Space Acquisition II Corp. (Director · Nov 12, 2024 – Nov 12, 2024 · Past); Xynomic Pharmaceuticals Holdings Inc (CEO and CFO, Director · Jun 19, 2017 – Jun 19, 2017 · Past); Tianyin Pharmaceutical Co Inc (CFO & Director & CBDO, Director · Apr 1, 2010 – May 28, 2014 · Past) | Director · Since at least Mar 18, 2026 |
| Erqi Wang | Chief Executive Officer, Director · Since at least Mar 18, 2026 |
| Ning Xue | Director · Since at least Jul 16, 2026 |
| Oliver St Clair Franklin Jr | Director · Since at least Mar 18, 2026 |
| Yanru Guo | Director · Since at least Mar 18, 2026 |
| Ziqiang Wang | Chief Financial Officer, Director · Since at least Mar 18, 2026 |
Log in to ask 6ix AI your own questions about Jin Medical International Ltd.